Zydus Wellness is currently trading at Rs. 1325.40, up by 21.45 points or 1.65% from its previous closing of Rs. 1303.95 on the BSE.
The scrip opened at Rs. 1310.10 and has touched a high and low of Rs. 1343.05 and Rs. 1310.10 respectively. So far 598 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1830.00 on 03-Sep-2018 and a 52 week low of Rs. 918.10 on 14-Dec-2017.
Last one week high and low of the scrip stood at Rs. 1,343.05 and Rs. 1,201.60 respectively. The current market cap of the company is Rs. 5199.13 crore.
The promoters holding in the company stood at 72.54%, while Institutions and Non-Institutions held 13.64% and 13.82% respectively.
Zydus Wellness (ZWL) has received approval from the Competition Commission of India (CCI) for the company’s acquisition of Heinz India jointly with Cadila Healthcare.
The definitive agreement in relation to this acquisition was signed on October 24, 2018.
ZWL will primarily be acquiring the business related to the four brands - Glucon-D, Nycil, Sampriti and Complan, through this transaction. The CCI approval takes ZWL one step closer to completing the acquisition, which is expected to unlock significant value for ZWL by enriching its portfolio and expanding the reach of its distribution network.
Zydus Wellness is an integrated consumer company. The company is engaged in the development, production, marketing and distribution of health and wellness products.
Company Name | CMP |
---|---|
Nestle | 2210.45 |
Britannia Inds | 4804.35 |
Varun Beverages | 626.85 |
Marico | 590.80 |
Hatsun Agro Product | 1044.75 |
View more.. |